CHU UCL Namur-Site de Saint Elisabeth

Namur 5000

0 studies enrolling now · 2 studies all time

What they study most

HER2 Positive Breast Cancer, Urothelial Carcinoma

Studies at this site

• A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 — Recruiting now
• A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer — Completed